AI-generated · cited to primary sources · not investment advice · How we research
Park Medi World
Our verdict on Park Medi World isn’t the consensus take — see where we landed, and the one risk the bull case glosses over.
See the verdict — free →Does management do what it says?
The company expects the full impact of the CGHS rate hike (estimated at 12-15%) to reflect in finances by the second half of the next financial year. — target: 12% to 15% rate hike impact
“But generally, the overall rate hike, what we envisage has been about 12% to 15%. And the effectivity of that will come probably in the, as you said, second half of the next financial year.”
The company aims to reach optimum occupancy of 75% to 80% at the new 360-bed Agra facility within the next three years. — target: 75% to 80% occupancy
“See, currently our main focus would be that, in 360 bed, we reach the optimum occupancy of about 75% to 80%... we look at ramping up the occupancy to about 75% to 80% in the coming three years.”
See the full cited Management analysis of Park Medi World
How durable is the business?
The company is aggressively expanding its North India footprint through new acquisitions in New Delhi (Febris) and Agra (KPIMS), increasing its total bed capacity. (1 expanding)
“Punjab: 900 beds out of 3,250 total (as of 30-Sep-25)”
The private insurance (TPA) segment is expanding as part of a long-term strategy to reach a 25% share, up from 16% at the time of the IPO. (1 expanding across 1 engine)
“Self-pay is 9% and TPA is 8%.”
See the full cited Business Model analysis of Park Medi World
Where does growth come from?
The company is in an aggressive expansion phase, adding 660 beds in the current fiscal year alone, with a clear roadmap to reach 5,260 beds by FY28. (2 accelerating across 2 signals, 1 leading indicator)
“In FY ‘27, we are adding 500 more beds... and in FY ‘28, we will be aspiring for 850 beds... which should take us to roughly 5,260 beds.”
A substantial government rate hike of 12-15% has been announced; while not yet in the numbers, it represents a major upcoming revenue catalyst for FY27. (1 new trend across 1 signal)
“generally, the overall rate hike, what we envisage has been about 12% to 15%... we will be looking at about 7.5% increment in our revenue and EBITDA.”
See the full cited Future Growth analysis of Park Medi World
What could break the thesis?
The risk is easing as the company is seeing a structural shift toward private insurance (TPA) and self-pay, which improved from 16% to 17% and is projected to reach 25% in a year. Additionally, a significant CGHS rate hike of 12-15% is expected to improve margins. (2 easing, 1 intensifying, 1 high-severity)
“If I talk about as of 31st December, our payer mix, you know, that relate to government scheme that came down to 83% from 84%.”
Execution is on track with 660 beds (Agra and Panchkula) being commissioned in Q4 FY26. Management has a clear roadmap for FY27 (500 beds) and FY28 (850 beds) and is maintaining a low blended capex of INR 30-35 lakhs per bed. (2 stable, 1 high-severity)
“In FY ‘28, we will be aspiring for 850 beds... which should take us to roughly 5,260 beds.”
See the full cited Risk analysis of Park Medi World
Read the full thesis on Park Medi World
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.